Navigation Links
Acting Surgeon General Announces National Initiatives to Protect Children by Reducing Exposure to Secondhand Smoke
Date:9/13/2007

WASHINGTON, Sept. 13 /PRNewswire-USNewswire/ -- The following was released today by the U.S. Department of Health and Human Services:

WHO: Kenneth Moritsugu, M.D. M.P.H., Acting U.S Surgeon General

Jay E. Berkelhamer, M.D., F.A.A.P., President, American

Academy of Pediatrics

Daniel Schneider, J.D., Acting Assistant Secretary, HHS

Administration for Children and Families

Elizabeth Cotsworth, Director, Office of Radiation and Indoor

Air, Environmental Protection Agency

WHAT: Acting Surgeon General Kenneth Moritsugu will join together

with the American Academy of Pediatrics to announce a new

partnership to protect the nation's children from secondhand

smoke. The Environmental Protection Agency and the

Administration for Children and Families will also highlight

their joint initiative to reduce children's secondhand smoke

exposure among the hundreds of thousands of children who

participate in the national Head Start program.

WHEN: 10:00 a.m. (ET) on September 18, 2007 **Note: Media should

arrive by 9:30 a.m.

To confirm attendance, please RSVP at

http://www.sgsecondhandsmokereport.org by September 17th.

WHERE: Edward C. Mazique Parent Child Center

1719 13th Street, NW

Washington, D.C. 20009

CONTACT: HHS Office of Public Health and Science

(202) 690-7694

EDITOR'S NOTE: The Acting Surgeon General will also release Children and Secondhand Smoke Exposure, an excerpt from the 2006 Surgeon General's Report on The Health Consequences of Involuntary Exposure to Tobacco Smoke, and a new bilingual toolki
'/>"/>

SOURCE U.S. Department of Health and Human Services
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Use of a fast-acting insulin analog to control diabetic ketoacidosis in Children
2. NHS acting chief’s intervie
3. Patient Refuses To Be Treated In Local Hospital Due To The Fear Of Contracting MRSA
4. Public Service in South Africa at a High Risk of Contracting AIDS
5. Australian beauty with roots in India open to acting in Bollywood
6. Overreacting to the effects of Radiation
7. Patient and Staff of Two Hospitals at Risk Of Contracting TB
8. “Don’t fear long haul flights!” Vascular surgeon tells travelrs
9. Surgeons implant second artificial heart
10. Computers may become surgeons
11. Specialist surgeon not imperative in melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)... Yesterday, America,s He...h insurance industry had decided to support an "in...health insurance or pay a fine, combined with "gua...pted regardless of health status. , , But ..., which has several health insurance company membe...
(Date:11/20/2008)... An investor group in Trinity,Bio...er and manufacturer of,diagnostic products whose ...ry,Receipts on NASDAQ, is encouraged that Clint S...rs. , Commenting on the news, Tom Reidy sta...erve as an independent director, bringing the tota...
(Date:11/20/2008)... Alzheimer,s relatives at risk for hospital visits...lthDay News) -- The stress of providing care for a...of family caregivers having at least one emergency...Indiana University study. , It,s long been rec... is difficult, but the Indiana University research...
(Date:11/20/2008)... infection that can cause meningitis, pneumonia in...0 (HealthDay News) -- U.S. health officials said T... to monitor Hib infections, one of the most import... , Though the agency has yet to see an increase...d by a disruption in the supply of vaccine that ha...
Breaking Medicine News(10 mins):Health News:CAHI Stands by Its Principles for Health Insurance Reform 2Health News:Investor Group Commends Clint Severson for Joining Trinity Biotech's Board of Directors 2Health News:When the Caregiver Becomes the Patient 2Health News:CDC Monitors Shortage of Hib Vaccine 2Health News:CDC Monitors Shortage of Hib Vaccine 3
Dengue, the mosquito-transmitted lethal disease that has claimed 15 lives and afflicted 1,000 people in West Bengal so far, has been declared an epidemic by the state government.// State Health Direct
...ffering from anorexia nervosa have the similar bra...r emotional disorders. // The study was published ...hiatry. Previous evidence has suggested that alter... brain chemical involved in communication between ...
...rch findings elevate the role of fibres further by...s may slow atherosclerosis and plaque build-up in ...studies linked dietary fibre, particularly cereal ...sease and death. Investigating the effect of dieta...
...f the clinical study carried out by Professor Ian ...in New Zealand has found that the drug Zometa manu...better than the drug Actonel produced by Procter a...tion in which the bones breaks or becomes weak fas...
Other Medicine News:
(Date:11/20/2008)... Nov. 20 Radius Health ("Radius") ...15 million to its second institutional financing r...5 million and the total amount raised since the co...institutional investors participated in the financ...uding MPM Capital, The Wellcome Trust, HealthCare ...
(Date:11/19/2008)...lif., Nov. 19 Amgen,(Na... Company, a subsidiary of,Takeda Pharmaceutical C...enrollment in the Phase 3 MONET1 trial evaluating ...l and carboplatin for the first-line treatment of,...een temporarily suspended,following a planned saf...
(Date:11/19/2008)...ion Payment from Roche- , , MONTVALE, N.J.,...uticals Corp. (Nasdaq: MEMY ) today announced th...se 2 trial of R3487/MEM 3454, its lead alpha-7 nic...ssociated with schizophrenia (CIAS). The Company ...triggering a $5.0 million payment from its partner...
(Date:11/18/2008)...ociation,s 2008 Faces of Influenza survey undersco...ainst influenza; Mother and Gold Medalist Kristi Y...Nov. 18 While 78 percent of mother... and potentially life-threatening disease that can...amilies will get vaccinated this season, according...
Breaking Medicine Technology:Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Anthem Blue Cross and Blue Shield in Colorado Introduces Industry Leading and Comprehensive Transparency Initiative to Colorado 24950 1Anthem Blue Cross and Blue Shield in Colorado Introduces Industry Leading and Comprehensive Transparency Initiative to Colorado 24950 2Anthem Blue Cross and Blue Shield in Colorado Introduces Industry Leading and Comprehensive Transparency Initiative to Colorado 24950 31st World Congress On Interventional Therapies for Type 2 Diabetes 24947 11st World Congress On Interventional Therapies for Type 2 Diabetes 24947 21st World Congress On Interventional Therapies for Type 2 Diabetes 24947 31st World Congress On Interventional Therapies for Type 2 Diabetes 24947 4Mayo Clinic Experts Offer Insights on Olympians 24944 1Mayo Clinic Experts Offer Insights on Olympians 24944 2Mayo Clinic Experts Offer Insights on Olympians 24944 3Regence Introduces Rewards to Activate Members Toward Healthy Living 24941 1Regence Introduces Rewards to Activate Members Toward Healthy Living 24941 2Regence Introduces Rewards to Activate Members Toward Healthy Living 24941 3
...itial Phase II Study Results Presented at Society ...June 04, 2007 /PRNewswire-FirstCall/ --,Immunomedi...developing monoclonal antibodies to treat cancer a...s anti-carcinoembryonic antigen,(CEA) antibody, la...31, was found to be safe and active when given in ...
...AGO--(BUSINESS WIRE)--Jun 4, 2007 - Pfizer announc...onal oral, selective inhibitor,of VEGFR 1, 2,3 (va...) combined with gemcitabine showed a trend towards...advanced pancreatic cancer,compared with gemcitab...ndomized Phase II trial., These data were presente...
Other Medicine Technology:Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 2Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 3Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 4Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 5New Data Show Pfizer's Axitinib Prolonged Overall Survival in,Advanced Pancreatic Cancer When Combined with Standard of Care,Chemotherapy 2New Data Show Pfizer's Axitinib Prolonged Overall Survival in,Advanced Pancreatic Cancer When Combined with Standard of Care,Chemotherapy 3New Data Show Pfizer's Axitinib Prolonged Overall Survival in,Advanced Pancreatic Cancer When Combined with Standard of Care,Chemotherapy 4
The Model 900 is a new desk top pulse oximeter that was designed for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring. It also incorporates an LCD waveform m
The Model 305 is a hand-held, portable, lightweight oximeter designed for spot checking. It has a NiCad rechargeable battery.
A pocket-sized pulse oximeter. Perfect for the physician's office, emergency medicine, hospitals and clinics, and home health care.
Cost-effective, portable, continuous, or spot check pulse oximetry monitoring system with alarms and an internal rechargeable battery. Clinician, Home-Use and Sleep Study modes make it ideal for use
Medicine Products: